麦默通乳腺微创旋切术在38例注射式隆乳材料取出中的应用

Removal of injected material for breast augmentation with Mammotome minimally invasive system: 38 cases

目的：探讨超声引导下麦默通乳腺微创旋切术在注射式隆乳材料聚丙烯酰胺凝胶（ PAHG）取出中的临床价值。方法回顾性分析2009年2月至2013年4月本科38例行超声引导下麦默通乳腺微创旋切术取出PAHG的注射式隆乳患者资料，并记录术后病理结果和随访情况。结果38例注射式隆乳材料PAHG被取出，其中3例出现皮下积液。全部患者均未发生感染。所有患者术后随访3.0～24.0个月，8例发生少量注射物残留，全部病例乳房外形满意。结论麦默通是一项创伤小、并发症少的乳腺微创技术，对注射式隆乳材料PAHG的取出安全、有效。

Objective To explore the clinical application of Mammotome minimally invasive system in the removal of injected breast augmentation material polyacrylamide hydrogel （ PAHG ） . Methods We retrospectively analyzed totally 38 cases who underwent the removal of injected breast augmentation material PAHG using Mammotome minimally invasive system under the guidance of ultrasound from February 2009 to April 2013 .The postoperative pathological findings and follow-up results were recorded .Results PAHG was removed in all 38 cases.Subcutaneous fluid was observed in 3 cases, and no postoperative infection was found . All cases were followed up for 3.0-24.0 months, and 8 cases were found with residual PAHG , and all patients were satisfied with breast appearance .Conclusion As a minimally invasive technique with few complications , Mammotome is safe, effective and feasible for the removal of injected breast augmentation material PAHG .